Legal & General Group Plc - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 81 filers reported holding RELMADA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$6,947
-35.2%
3,0740.0%0.00%
Q4 2022$10,728
-96.7%
3,074
-65.5%
0.00%
Q3 2022$329,000
+126.9%
8,903
+15.9%
0.00%
Q2 2022$145,000
-31.3%
7,679
-1.6%
0.00%
Q1 2022$211,000
+37.9%
7,801
+15.3%
0.00%
Q4 2021$153,000
+33.0%
6,768
+54.1%
0.00%
Q3 2021$115,000
+66.7%
4,391
+103.3%
0.00%
Q2 2021$69,000
-9.2%
2,1600.0%0.00%
Q1 2021$76,000
+5.6%
2,160
-4.1%
0.00%
Q4 2020$72,000
-14.3%
2,2520.0%0.00%
Q3 2020$84,000
-33.9%
2,252
-20.6%
0.00%
Q2 2020$127,0002,8350.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders